Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Relationship of serum IL-13 and eotaxin level with airway hyperresponsiveness in children with asthma

소아 천식 환아에서 혈청 IL-13 및 eotaxin 농도와 기관지과민성의 관계

  • Park, Eun Young (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shim, Jung Yeon (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Yoo, Myung Hwan (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Kim, Deok Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Shim, Jae Won (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Jung, Hye Lim (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine) ;
  • Park, Moon Soo (Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine)
  • 박은영 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 심정연 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • ;
  • 김덕수 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 심재원 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 정혜림 (성균관대학교 의과대학 강북삼성병원 소아과) ;
  • 박문수 (성균관대학교 의과대학 강북삼성병원 소아과)
  • Received : 2006.03.16
  • Accepted : 2006.05.15
  • Published : 2006.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Asthma is characterized by the presence of airway hyperresponsiveness(AHR) and inflammation. The extensive eosinophil infiltration into the lung is the hallmark of asthma and contributes to the damage of respiratory epithelium during late phase airway responses. Eotaxin is the major eosinophil chemoattractant found in bronchoalveolar lavage(BAL) fluid of allergic inflammation. IL-13 has been known to induce the expression of exotaxin and eosinophilia. IL-13 also induces airway inflammation, mucus production and leads to marked fibrosis, airway remodeling and AHR. We investigated whether serum IL-13 levels can reflect the presence of airway hyperresponsiveness in children with asthma, and the relationship between serum IL-13 and eotaxin levels. Methods : Using sandwich enzyme-linked immunosorbent assay, the serum IL-13 and eotaxin levels were measured in 13 atopic asthmatics, 5 atopic non-asthmatics and 12 control subjects. Metacholine challenge tests were performed in all subjects. Airway hyperresponsiveness to metacholine was expressed as provocative concentration of metacholine causing a 20% fall in FEV1[$PC_{20}mg/mL$]. $PC_{20}$ value of 25 mg/mL was used as a cut-off for defining a AHR. Results : Serum IL-13 levels showed positive correlation with eotaxin levels. Serum IL-13 and eotaxin levels showed no differences among atopic asthmatics, atopic non-asthmatics and control subjects. And there were no differences serum IL-13 and eotaxin levels in children with and without AHR and atopy. Serum IL-13 and eotaxin levels did not correlate with $logPC_{20}$ levels. Conclusion : IL-13 is closely related to the eotaxin release. But serum IL-13 and eotaxin per se can't predict the severity of airway hyperresponsiveness. IL-13 and eotaxin may have local effect on respiratory epithelium or there can be some factors to induce airway hyperresponsiveness other than serum IL-13 in asthmatic airways.

목 적 : 기관지 천식은 만성적인 기도염증과 기관지과민성을 특징으로 하는 질환이다. 항원으로 유발한 폐조직이나, 기관지세척액에서 호산구 및 여러 염증세포가 관찰되며 eotaxin과 Th2 세포에서 유래한 여러 사이토카인의 증가가 관찰된다. 이 중 IL-13은 조직 호산구증에 중요한 케모카인인 eotaxin의 발현을 증가시키며, 만성염증, 점액분비증가, 평활근수축 등을 유발하여 기관지과민성을 일으키는 강력한 사이토카인이다. 본 연구는 혈청에서 IL-13 및 eotxin 농도를 측정하여 두 인자간의 상관관계를 알아보고, 기관지과민성 예측을 위한 간접평가방법으로서의 임상적 유용성을 알아보고자 하였다. 방 법 : 아토피 천식 환아 13명, 아토피 비천식 환아 5명 그리고 건강한 어린이 13명을 대상으로 하여, 혈청에서 IL-13 및 eotaxin 농도를 측정하고 IL-13과 eotaxin과의 상관관계 및 각 군간 비교를 하였다. 또한 기관지 과민성 및 아토피 유무에 따른 혈청 IL-13, eotaxin 농도를 조사하였다. 결 과 : 혈청 IL-13 농도와 eotaxin 농도 사이에는 양의 상관관계가 존재하였다. 아토피 천식군, 아토피 비천식군 및 대조군에서 혈청 IL-13 및 eotaxin 농도 차이는 없었다. 기관지 과민성 및 아토피 여부에 따라 혈청 IL-13 및 eotaxin 농도를 비교하였으나, 이들간에 유의한 차이는 없었다. $LogPC_{20}$와 혈청 IL-13, eotaxin 농도간에는 유의한 상관관계가 없었다. 결 론 : IL-13과 eotaxin의 분비는 밀접한 상관관계가 있다. 그러나, 말초 혈액내 IL-13 및 eotxin 농도는 기관지과민성 및 심한 정도를 반영하지 못하며, 기관지과민성은 IL-13 및 eotaxin의 기도상피세포 및 평활근세포에 대한 국소작용에 의한 것으로 생각된다.

Keywords

References

  1. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Inter leukin-13 : Central mediator of allergic asthma. Science 1998;282:2258-61 https://doi.org/10.1126/science.282.5397.2258
  2. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflmmation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clincal Invest 1999;103:779-89 https://doi.org/10.1172/JCI5909
  3. Zimmermann N, Hershey GK, Foster PS, Rothenberg ME. Chemokines in asthma : Cooperative interaction between chemokines and IL-13. J Allergy Clin Immunol 2003;111: 227-42 https://doi.org/10.1067/mai.2003.139
  4. Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 2004;28:224-32 https://doi.org/10.1016/j.cyto.2004.08.007
  5. Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, et al. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol 2001;167:4668-75 https://doi.org/10.4049/jimmunol.167.8.4668
  6. Jung EM, Kim HS, Kang IJ. A 10 year follow-up childhood asthma : Potential risk factors on persistence of nonspecific bronchial hyperresponsiveness. Pediatr Allergy Respir Dis 2002;12:82-92
  7. Yang M, Hogan SP, Mahalingam S, Pope SM, Zimmermann N, Fulkerson P, et al. Eotaxin-2 and IL-5 cooperate in the lung to regulate IL-13 production and airway eosinophilia and hyperreactivity. J Allergy Clin Immunol 2003; 112:935-43 https://doi.org/10.1016/j.jaci.2003.08.010
  8. Li L, Xia Y, Nguyen A, Lai YH, Feng L, Mosmann TR, et al. Effect of Th2 cytokines on chemokine expression in the lung : IL-13 potently induces eotaxin expression by airway epithelial cells. J Immunol 1999;162:2477-87
  9. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, et al. IL-13 induces eosinophil recruitment into the lung by an IL-5 and eotaxin dependent mechanism. J Allergy Clin Immunol 2001;108:594-601 https://doi.org/10.1067/mai.2001.118600
  10. Matsukura S, Stellato C, Georas SN, Casolaro V, Plitt JR, Miura K, et al. Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism. Am J Respir Cell Mol Biol 2001;24:755-61 https://doi.org/10.1165/ajrcmb.24.6.4351
  11. Moore PE, Church TL, Chism DD, Panettieri RA Jr, Shore SA. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells : a role for ERK. Am J Physiol Lung Cell Mol Physiol 2002;282:847-52 https://doi.org/10.1152/ajplung.00245.2001
  12. Schmid-Grendelmeier P, Altznauer F, Fischer B, Bizer C, Straumann A, Menz G, et al. Eosinophils express functional IL-13, in eosinophilic inflammatory disease. J Immunol 2002;169:1021-7 https://doi.org/10.4049/jimmunol.169.2.1021
  13. Kim JT. Evaluation of inflammation in childhood asthma; Non-invasive measurement. J Korean Pediatr Soc 2001;44: 334-9
  14. The Korean Academy of Pediatric Allergy and Respiratory Disease. The guideline for diagnosis and management of childhood asthma. 2nd ed. Seoul : Sowha Co, 1999:5-87
  15. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323- 58 https://doi.org/10.1016/0091-6749(75)90107-4
  16. Arima K, Umeshita-Suyama R, Sakata Y, Akaiwa M, Mao XQ, Enomoto T, et al. Upregulation of IL-13 concentraion in vivo the IL-13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002;109:980-7 https://doi.org/10.1067/mai.2002.124656
  17. O'Bryan L, Pinkston P, Kumaraswami V, Vijayan V, Yenokida G, Rosenberg HF, et al. Localized eosinophil degranulation mediates disease in tropical pulmonary eosinophilia. Infect Immun 2003;71:1337-42 https://doi.org/10.1128/IAI.71.3.1337-1342.2003
  18. Min JW, Jang AS, Park SM, Lee JH, Park SW, Park CS. Comparison of plasma eotaxin family level in aspirininduced and aspirin-tolerant asthma patient. Chest 2005;128: 127-32
  19. Li J, Saito H, Crawford L, Inman MD, Cyr MM, Denburg JA. Haemopoietic mechanisms in murine allergic upper and lower airway inflammation. Immunology 2005;114:386-96 https://doi.org/10.1111/j.1365-2567.2005.02109.x
  20. Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, et al. The role of IL-13 in established allergic airway disease. J Immunol 2002;169:6482-9 https://doi.org/10.4049/jimmunol.169.11.6482
  21. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 2002;26:202-8 https://doi.org/10.1165/ajrcmb.26.2.4600
  22. Chang JY, Shin SA, Oh JW, Lee HB. Crucial factors for bronchial hyperresponsiveness in children with mild asthma. Pediatr Allergy Respir Dis 2005;15:142-9
  23. Shin SA, Oh JW, Lee HB, Kim NS, Lee HB. Relationship between airway hyperresposiveness and duration of asthma in children. J Asthma Allergy Clin Immunol 2003;23:77-83
  24. Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, Poulsen K, et al. Association between an interleukin-13 promotor polymorphism and atopy. Eur J Immunogenet 2003;30:355-9 https://doi.org/10.1046/j.1365-2370.2003.00416.x
  25. Zhou G, Zhai Y, Dong X, Zhang X, He F, Zhou K, et al. Haplotype structure and evidence for positive selection at the human IL13 locus. Mol Biol Evol 2004;21:29-35